Clincosm LogoSign in Get a demo

Urologic Neoplasms

Showing 26 - 43 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urologic Tumors Trial in Stanford (zoledronic acid)

Terminated
  • Urologic Neoplasms
  • zoledronic acid
  • Stanford, California
    Stanford University School of Medicine
Mar 16, 2020

Laparoscopic Partial Nephrectomy for cT1 Tumors

Completed
  • Renal Cancer
  • +12 more
    • Samsun, Turkey
    • +1 more
    Dec 27, 2019

    Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of varlilumab and sunitinib)

    Terminated
    • Carcinoma, Renal Cell
    • +8 more
    • Combination of varlilumab and sunitinib
    • Birmingham, Alabama
    • +8 more
    Jul 24, 2018

    Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

    Terminated
    • Carcinoma, Renal Cell
    • +13 more
    • Combination of Varlilumab and Atezolizumab
    • San Francisco, California
    • +3 more
    Apr 26, 2018

    Colorectal Tumors, Urologic Tumors, Urologic Diseases Trial in Hong Kong (Robotic single port surgery and NOTES)

    Completed
    • Colorectal Neoplasms
    • +8 more
    • Robotic single port surgery and NOTES
    • Hong Kong, China
      Prince of Wales Hospital, The Chinese University of Hong Kong
    Feb 5, 2018

    Urologic Tumors, Prostate Cancer, Prostate Cancer Metastatic Disease Trial in Stanford (Docetaxel, Biosyn, Prednisone)

    Terminated
    • Urologic Neoplasms
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Mar 13, 2017

    Urologic Tumors, Metastatic Bladder Cancer, Urinary Tract Tumors Trial in Worldwide (OGX-427 600 mg, OGX-427 1000 mg, Placebo)

    Completed
    • Urologic Neoplasms
    • +2 more
    • OGX-427 600 mg
    • +5 more
    • Duarte, California
    • +54 more
    Oct 6, 2016

    Urinary Bladder Tumors, Urologic Tumors, Tumors Trial in Delhi (40 mg MMC in 40 mL TC-3., 80 mg MMC in 40 mL TC-3.)

    Completed
    • Urinary Bladder Neoplasms
    • +4 more
    • 40 mg MMC in 40 mL TC-3.
    • 80 mg MMC in 40 mL TC-3.
    • Delhi, New Delhi, India
      Rajiv Gandhi Cancer Institute & Research Center
    Sep 7, 2016

    Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial (Synergo + MMC, Bacillus Calmette-Guérin)

    Withdrawn
    • Urinary Bladder Neoplasms
    • +6 more
    • Synergo + MMC
    • Bacillus Calmette-Guérin
    • (no location specified)
    Mar 31, 2015

    Urologic Tumors Trial in United States (Trastuzumab, Paclitaxel, Carboplatin)

    Completed
    • Urologic Neoplasms
    • Duarte, California
    • +10 more
    Jan 20, 2015

    Urinary Bladder Diseases, Urinary Bladder Tumors, Urinary Bladder Cancer Trial in Worldwide (Synergo + MMC, Bacillus

    Terminated
    • Urinary Bladder Diseases
    • +7 more
    • Synergo + MMC
    • Bacillus Calmette-Guérin
    • Vienna, Austria
    • +7 more
    Oct 5, 2014

    Urologic Tumors Trial in Spain (pemetrexed, cisplatin)

    Completed
    Has Results
    • Urologic Neoplasms
    • Barcelona, Spain
    • +4 more
    Oct 20, 2010

    Urologic Tumors Trial (S-8184 Paclitaxel Injectable Emulsion, Experimental Arm: TOCOSOL Paclitaxel)

    Completed
    • Urologic Neoplasms
    • S-8184 Paclitaxel Injectable Emulsion
    • Experimental Arm: TOCOSOL Paclitaxel
    • (no location specified)
    Jun 2, 2009

    Inherited Urologic Malignant Disorders: Collection of Samples

    Completed
    • Neoplastic Syndromes, Hereditary
    • Urologic Neoplasms
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008

      Urologic Tumors, Carcinoma, Transitional Cell Trial in Japan (Gemcitabine)

      Completed
      • Urologic Neoplasms
      • Carcinoma, Transitional Cell
      • Fukuoka, Japan
      • +11 more
      Nov 5, 2007

      Carcinoma, Renal Cell, Urogenital Tumors, Urologic Tumors Trial in Houston (motexafin gadolinium)

      Completed
      • Carcinoma, Renal Cell
      • +3 more
      • motexafin gadolinium
      • Houston, Texas
        Methodist Hospital
      Mar 2, 2007

      Urologic Tumors, Metastases, Tumor Trial in United States (pemetrexed)

      Completed
      • Urologic Neoplasms
      • Metastases, Neoplasm
      • Los Angeles, California
      • +19 more
      Jul 18, 2006

      Urologic Tumors Trial in Finland, France, Germany (ALIMTA, gemcitabine)

      Completed
      • Urologic Neoplasms
      • Helsinki, Finland
      • +8 more
      Jul 18, 2006